Back to search results

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Abroad (travel likely)RecruitingPHASE3

Conditions

Chronic Coronary Syndrome · Stable Coronary Artery Disease CAD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Clinical Hospital in Bialystok, Bialystok, Poland

    Contact: Study coordinator (Szymon Kocanda, MD, PhD)

  • Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

    Contact: Study coordinator (Wojciech Pawliszak, MD, PhD)

  • Medical University of Gdansk, Gdansk, Poland

    Contact: Study coordinator (Andrzej Los, MD, PhD)

  • Regional Specialist Hospital in Grudziadz, Grudziądz, Poland

    Contact: Study coordinator (Marian Burysz, MD, PhD)

  • Upper-Silesian Heart Center, Katowice, Poland

  • John Paul II Hospital, Krakow, Poland

    Contact: Study coordinator (Janusz Konstanty-Kalandyk, MD, PhD)

  • Medical University of Lodz, Lodz, Poland

    Contact: Study coordinator (Michal Krejca, MD, PhD)

  • Zbigniew Religa Heart Center "Medinet", Nowa Sól, Poland

    Contact: Study coordinator (Sleiman Sebastian Aboul-Hassan, MD, PhD)

  • Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland

    Contact: Study coordinator (Anna Witt-Majchrzak, MD, PhD)

  • Institute of Medical Sciences in Opole, Opole, Poland

    Contact: Study coordinator (Marek Cisowski, MD, PhD)

  • J. Struś Hospital, Poznan, Poland

    Contact: Study coordinator (Pawel Bugajski, MD, PhD)

  • Poznan University of Medical Sciences, Poznan, Poland

  • Pomeranian Medical University, Szczecin, Poland

    Contact: Study coordinator (Jerzy Pacholewicz, MD, PhD)

  • Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland

  • Medicover Hospital, Warsaw, Poland

    Contact: Study coordinator (Krzysztof Wrobel, MD, PhD)

  • Wroclaw Medical University, Wroclaw, Poland

  • Zbigniew Religa Heart Center "Medinet", Wroclaw, Poland

    Contact: Study coordinator (Mikolaj Berezowski, MD)

  • Silesian Centre for Heart Diseases in Zabrze, Zabrze, Poland

    Contact: Study coordinator (Tomasz Hrapkowicz, MD, PhD)
Study leads

  • Sleiman Sebastian Aboul-Hassan, MD, PhD

    Principal Investigator

    Zbigniew Religa Heart Center "Medinet"

View source on ClinicalTrials.gov(opens in a new tab)